Given they have already advised revenue in excess of $19M and the inventory is going to be capitalised, I put the FY loss at $18M - $20M (6.0c - 6.7c per share).
The muting of capital raising is interesting because they still had $18M of cash at 30 June. Why now?
Good news has to be close with the DTT trial although I noted implants dropped off in August.
Cap raising through shares is suicide at the current SP, so what is going on?
VCR Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
